nach oben

Calcified Tissue International

Erschienen in:

26.05.2018 | Original Research

Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome

verfasst von: Lijun Xu, Lixia Zhang, Zhifang Wang, Chong Li, Shan Li, Li Li, Qianying Fan, Lili Zheng

Erschienen in: Calcified Tissue International | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Postmenopausal osteoporosis induced by estrogen deficiency causes inadequate new bone formation and affects millions of women worldwide. Melatonin can improve bone mineral density at the femoral neck in postmenopausal women with osteopenia. This study aimed to investigate the mechanism of melatonin in estrogen deficiency-induced osteoporosis by focusing on osteoblast differentiation. 12-week-old female C57BL/6J mice were ovariectomized (OVX) and intraperitoneally injected with 10 or 50 mg/kg of melatonin for 8 weeks. Micro-computerized tomography scanning demonstrated that melatonin alleviated OVX-induced bone loss in a dose-dependent manner. Serum levels of ALP and osteocalcin (OCN) were further increased, whereas tartrate-resistant acid phosphatase level was decreased by melatonin in OVX-treated mice. Melatonin promoted osteoblast differentiation in primary bone marrow mesenchymal stem cells from OVX mice. It also inhibited activation of NLRP3 inflammasome in femoral bone protein and in induced osteoblasts stimulated by OVX. Knockdown of NLRP3 attenuated OVX-induced repression of osteogenic differentiation. The NLRP3 inflammasome activator monosodium urate partly abrogated the effect of melatonin on the expression of osteoblastogenic markers, including Runx2 and OCN. Additionally, the results showed that melatonin suppressed NLRP3 inflammasome activation by regulating Wnt/β-catenin signaling, which was confirmed by the Wnt/β-catenin inhibitor recombinant DKK1. These results indicated that melatonin ameliorates estrogen deficiency-induced osteoporosis and impaired osteogenic differentiation potential by suppressing activation of the NLRP3 inflammasome via mediating the Wnt/β-catenin pathway.

Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377(9773):1276–1287. https://doi.org/10.1016/S0140-6736(10)62349-5 CrossRefPubMedPubMedCentral

Krassas GE, Papadopoulou P (2001) Oestrogen action on bone cells. J Musculoskelet Neuronal Interact 2(2):143–151PubMed

Liu W, Zhou L, Zhou C, Zhang S, Jing J, Xie L, Sun N, Duan X, Jing W, Liang X, Zhao H, Ye L, Chen Q, Yuan Q (2016) GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation. Nat Commun 7:12794. https://doi.org/10.1038/ncomms12794 CrossRefPubMedPubMedCentral

Randell KM, Honkanen RJ, Kroger H, Saarikoski S (2002) Does hormone-replacement therapy prevent fractures in early postmenopausal women? J Bone Miner Res 17(3):528–533. https://doi.org/10.1359/jbmr.2002.17.3.528 CrossRefPubMed

de Villiers TJ (2015) The role of menopausal hormone therapy in the management of osteoporosis. Climacteric 18(Suppl 2):19–21. https://doi.org/10.3109/13697137.2015.1099806 CrossRefPubMed

Radogna F, Diederich M, Ghibelli L (2010) Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 80(12):1844–1852. https://doi.org/10.1016/j.bcp.2010.07.041 CrossRefPubMed

Favero G, Franceschetti L, Bonomini F, Rodella LF, Rezzani R (2017) Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int J Endocrinol 2017:1835195. https://doi.org/10.1155/2017/1835195 CrossRefPubMedPubMedCentral

Zhang WL, Meng HZ, Yang RF, Yang MW, Sun GH, Liu JH, Shi PX, Liu F, Yang B (2016) Melatonin suppresses autophagy in type 2 diabetic osteoporosis. Oncotarget 7(32):52179–52194. https://doi.org/10.18632/oncotarget.10538 PubMedPubMedCentralCrossRef

Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L (2015) Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res 59(2):221–229. https://doi.org/10.1111/jpi.12252 CrossRefPubMed

10.

Han Y, Kim YM, Kim HS, Lee KY (2017) Melatonin promotes osteoblast differentiation by regulating osterix protein stability and expression. Sci Rep 7(1):5716. https://doi.org/10.1038/s41598-017-06304-x CrossRefPubMedPubMedCentral

11.

Koyama H, Nakade O, Takada Y, Kaku T, Lau KH (2002) Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res 17(7):1219–1229. https://doi.org/10.1359/jbmr.2002.17.7.1219 CrossRefPubMed

12.

Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65(12 Pt 2):S147–S151

13.

Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141(11):3956–3964. https://doi.org/10.1210/endo.141.11.7739 CrossRefPubMed

14.

Sun X, Hao H, Han Q, Song X, Liu J, Dong L, Han W, Mu Y (2017) Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther 8(1):241. https://doi.org/10.1186/s13287-017-0668-1 CrossRefPubMedPubMedCentral

15.

Xu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X (2016) NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. Brain Behav Immun 56:175–186. https://doi.org/10.1016/j.bbi.2016.02.022 CrossRefPubMed

16.

Wang L, Chen K, Wan X, Wang F, Guo Z, Mo Z (2017) NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation. Biochem Biophys Res Commun 484(4):871–877. https://doi.org/10.1016/j.bbrc.2017.02.007 CrossRefPubMed

17.

Mansoori MN, Shukla P, Kakaji M, Tyagi AM, Srivastava K, Shukla M, Dixit M, Kureel J, Gupta S, Singh D (2016) IL-18BP is decreased in osteoporotic women: prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation. Sci Rep 6:33680. https://doi.org/10.1038/srep33680 CrossRefPubMedPubMedCentral

18.

Cao S, Shrestha S, Li J, Yu X, Chen J, Yan F, Ying G, Gu C, Wang L, Chen G (2017) Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation. Sci Rep 7(1):2417. https://doi.org/10.1038/s41598-017-02679-z CrossRefPubMedPubMedCentral

19.

Cao Z, Fang Y, Lu Y, Tan D, Du C, Li Y, Ma Q, Yu J, Chen M, Zhou C, Pei L, Zhang L, Ran H, He M, Yu Z, Zhou Z (2017) Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome. J Pineal Res. https://doi.org/10.1111/jpi.12389 PubMedCentralCrossRefPubMed

20.

Yang N, Wang G, Hu C, Shi Y, Liao L, Shi S, Cai Y, Cheng S, Wang X, Liu Y, Tang L, Ding Y, Jin Y (2013) Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res 28(3):559–573. https://doi.org/10.1002/jbmr.1798 CrossRefPubMed

21.

Park KH, Kang JW, Lee EM, Kim JS, Rhee YH, Kim M, Jeong SJ, Park YG, Kim SH (2011) Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. J Pineal Res 51(2):187–194. https://doi.org/10.1111/j.1600-079X.2011.00875.x CrossRefPubMed

22.

Chen EEM, Zhang W, Ye CCY, Gao X, Jiang LLJ, Zhao TTF, Pan ZZJ, Xue DDT (2017) Knockdown of SIRT7 enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly via activation of the Wnt/beta-catenin signaling pathway. Cell Death Dis 8(9):e3042. https://doi.org/10.1038/cddis.2017.429 CrossRefPubMedPubMedCentral

23.

Yue S, Zhu J, Zhang M, Li C, Zhou X, Zhou M, Ke M, Busuttil RW, Ying QL, Kupiec-Weglinski JW, Xia Q, Ke B (2016) The myeloid heat shock transcription factor 1/beta-catenin axis regulates NLR family, pyrin domain-containing 3 inflammasome activation in mouse liver ischemia/reperfusion injury. Hepatology 64(5):1683–1698. https://doi.org/10.1002/hep.28739 CrossRefPubMedPubMedCentral

24.

Feng J, Sun Q, Liu L, Xing D (2015) Photoactivation of TAZ via Akt/GSK3beta signaling pathway promotes osteogenic differentiation. Int J Biochem Cell Biol 66:59–68. https://doi.org/10.1016/j.biocel.2015.07.002 CrossRefPubMed

25.

Rubin R, Arzumanyan A, Soliera AR, Ross B, Peruzzi F, Prisco M (2007) Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal. J Cell Physiol 213(2):445–453. https://doi.org/10.1002/jcp.21185 CrossRefPubMedPubMedCentral

26.

Feng X, Zhang Y, Xu R, Xie X, Tao L, Gao H, Gao Y, He Z, Wang H (2010) Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis 208(2):396–405. https://doi.org/10.1016/j.atherosclerosis.2009.07.035 CrossRefPubMed

27.

Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L, Lo Cascio V (2009) Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum 60(11):3356–3365. https://doi.org/10.1002/art.24884 CrossRefPubMed

28.

Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, Zaidi M, Abe E (2003) Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 112(6):924–934. https://doi.org/10.1172/JCI15543 CrossRefPubMedPubMedCentral

29.

Charles-Harris M, Koch MA, Navarro M, Lacroix D, Engel E, Planell JA (2008) A PLA/calcium phosphate degradable composite material for bone tissue engineering: an in vitro study. J Mater Sci Mater Med 19(4):1503–1513. https://doi.org/10.1007/s10856-008-3390-9 CrossRefPubMed

30.

Zhang P, Liu Y, Wang Y, Zhang M, Lv L, Zhang X, Zhou Y (2017) SIRT6 promotes osteogenic differentiation of mesenchymal stem cells through BMP signaling. Sci Rep 7(1):10229. https://doi.org/10.1038/s41598-017-10323-z CrossRefPubMedPubMedCentral

31.

Ortiz F, Acuna-Castroviejo D, Doerrier C, Dayoub JC, Lopez LC, Venegas C, Garcia JA, Lopez A, Volt H, Luna-Sanchez M, Escames G (2015) Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis. J Pineal Res 58(1):34–49. https://doi.org/10.1111/jpi.12191 CrossRefPubMed

32.

Dong Y, Fan C, Hu W, Jiang S, Ma Z, Yan X, Deng C, Di S, Xin Z, Wu G, Yang Y, Reiter RJ, Liang G (2016) Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling. J Pineal Res 60(3):253–262. https://doi.org/10.1111/jpi.12300 CrossRefPubMed

33.

Zhang Y, Li X, Grailer JJ, Wang N, Wang M, Yao J, Zhong R, Gao GF, Ward PA, Tan DX, Li X (2016) Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. J Pineal Res 60(4):405–414. https://doi.org/10.1111/jpi.12322 CrossRefPubMed

34.

Son JH, Cho YC, Sung IY, Kim IR, Park BS, Kim YD (2014) Melatonin promotes osteoblast differentiation and mineralization of MC3T3-E1 cells under hypoxic conditions through activation of PKD/p38 pathways. J Pineal Res 57(4):385–392. https://doi.org/10.1111/jpi.12177 CrossRefPubMed

35.

Foo C, Frey S, Yang HH, Zellweger R, Filgueira L (2007) Downregulation of beta-catenin and transdifferentiation of human osteoblasts to adipocytes under estrogen deficiency. Gynecol Endocrinol 23(9):535–540. https://doi.org/10.1080/09513590701556483 CrossRefPubMed

36.

Ping Z, Hu X, Wang L, Shi J, Tao Y, Wu X, Hou Z, Guo X, Zhang W, Yang H, Xu Y, Wang Z, Geng D (2017) Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/beta-catenin signaling pathway. Acta Biomater 51:513–525. https://doi.org/10.1016/j.actbio.2017.01.034 CrossRefPubMed

37.

Takahashi-Yanaga F, Sasaguri T (2009) Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci 109(2):179–183CrossRefPubMed

38.

Ladizesky MG, Boggio V, Cutrera RA, Mondelo N, Mastaglia S, Somoza J, Cardinali DP (2006) Melatonin effect on bone metabolism in rats treated with methylprednisolone. J Pineal Res 40(4):297–304. https://doi.org/10.1111/j.1600-079X.2006.00316.x CrossRefPubMed

39.

Bonar SL, Brydges SD, Mueller JL, McGeough MD, Pena C, Chen D, Grimston SK, Hickman-Brecks CL, Ravindran S, McAlinden A, Novack DV, Kastner DL, Civitelli R, Hoffman HM, Mbalaviele G (2012) Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS ONE 7(4):e35979. https://doi.org/10.1371/journal.pone.0035979 CrossRefPubMedPubMedCentral

40.

Qi M, Zhang L, Ma Y, Shuai Y, Li L, Luo K, Liu W, Jin Y (2017) Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent Estrogen deficiency-induced osteoporosis. Theranostics 7(18):4498–4516. https://doi.org/10.7150/thno.17949 CrossRefPubMedPubMedCentral

41.

Rhee YH, Ahn JC (2016) Melatonin attenuated adipogenesis through reduction of the CCAAT/enhancer binding protein beta by regulating the glycogen synthase 3 beta in human mesenchymal stem cells. J Physiol Biochem 72(2):145–155. https://doi.org/10.1007/s13105-015-0463-3 CrossRefPubMed

Titel: Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome
verfasst von: Lijun Xu
Lixia Zhang
Zhifang Wang
Chong Li
Shan Li
Li Li
Qianying Fan
Lili Zheng
Publikationsdatum: 26.05.2018
Verlag: Springer US
Erschienen in: Calcified Tissue International / Ausgabe 4/2018
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-018-0428-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Periprosthetic Bone Mineral Density Around Uncemented Titanium Stems in the Second and Third Decade After Total Hip Arthroplasty: A DXA Study After 12, 17 and 21 Years

Effect of Continuous Intravenous Calcium Loading on Fibroblast Growth Factor 23 in Normal and Uremic Rats

A Challenging Case of Tumor-Induced Osteomalacia: Pathophysiological and Clinical Implications

Ficus deltoidea Prevented Bone Loss in Preclinical Osteoporosis/Osteoarthritis Model by Suppressing Inflammation

lncRNA HOTAIR Inhibits Mineralization in Osteoblastic Osteosarcoma Cells by Epigenetically Repressing ALPL

The Effect of β-Aminopropionitrile on Skeletal Micromorphology and Osteogenesis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin